Table 4 In-hospital and 1-year clinical follow-up of patients receiving stent implantation
In-hospital follow-up | ||||
|---|---|---|---|---|
BMI | p Trend | |||
≤24.9 | 25-30 | >30 | ||
Death (%) | 5.3 | 4.4 | 3.1 | 0.51 |
Myocardial infarction (%) | 0.6 | 0 | 2.0 | 0.09 |
Stroke (%) | 1.0 | 0 | 0 | 0.45 |
Repeat urgent revascularization (%) | ||||
PCI | 1.0 | 0 | 2.0 | 0.31 |
CABG | 1.0 | 0 | 0 | 0.35 |
CPR (%) | 2.0 | 2.0 | 0 | 0.41 |
Complete AV-block (%) | 1.0 | 0 | 1.0 | 0.25 |
Aneurysma spurium (%) | 1.0 | 2.0 | 0 | 0.43 |
Bleeding (%) | ||||
Major | 1.9 | 3.4 | 1.0 | 0.37 |
Minor | 6.9 | 7.3 | 3.1 | 0.33 |
Insignificant | 17.6 | 14.2 | 13.3 | 0.56 |
Triple antiplatelet therapy (%) | 14.5 | 9.4 | 10.6 | 0.27 |
One-year follow-up | ||||
Death (%) | 9.1 | 8.3 | 6.2 | 0.50 |
Myocardial infarction (%) | 5.7 | 4.7 | 5.1 | 0.92 |
Stroke (%) | 0 | 1.3 | 1.0 | 0.37 |
MACCE (%) | 15.1 | 13.4 | 10.2 | 0.53 |
TVR (%) | 7.0 | 5.0 | 4.0 | 0.47 |
Definite ST according ARC (%) | 4.0 | 2.0 | 1.0 | 0.26 |
ASS | 70.6 | 69.0 | 74.4 | 0.66 |
Clopidogrel | 46.9 | 37.6 | 48.9 | 0.13 |
Oral anticoagulation (%) | 4.2 | 8.5 | 5.6 | 0.24 |